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The continuous intravenous administration of isotopic bicarbonate (NaH13CO2) has been used for the determination of the
retention of the 13CO2 fraction or the 13CO2 recovered in expired air. This determination is important for the calculation of
substrate oxidation. The aim of the present study was to evaluate, in critically ill patients with sepsis under mechanical
ventilation, the 13CO2 recovery fraction in expired air after continuous intravenous infusion of NaH13CO2 (3.8 µmol/kg diluted in
0.9% saline in ddH2O). A prospective study was conducted on 10 patients with septic shock between the second and fifth day
of sepsis evolution (APACHE II, 25.9 ± 7.4). Initially, baseline CO2 was collected and indirect calorimetry was also performed.
A primer of 5 mL NaH13CO2 was administered followed by continuous infusion of 5 mL/h for 6 h. Six CO2 production (VCO2)
measurements (30 min each) were made with a portable metabolic cart connected to a respirator and hourly samples of expired
air were obtained using a 750-mL gas collecting bag attached to the outlet of the respirator. 13CO2 enrichment in expired air was
determined with a mass spectrometer. The patients presented a mean value of VCO2 of 182 ± 52 mL/min during the steady-state
phase. The mean recovery fraction was 0.68 ± 0.06%, which is less than that reported in the literature (0.82 ± 0.03%). This
suggests that the 13CO2 recovery fraction in septic patients following enteral feeding is incomplete, indicating retention of 13CO2
in the organism. The severity of septic shock in terms of the prognostic index APACHE II and the sepsis score was not associated
with the 13CO2 recovery fraction in expired air.
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Introduction
Sepsis, septic shock and multiple organ dysfunctions
are the main causes of death in intensive care units de-
spite the recent great technological and scientific advances
and efforts devoted to improving outcome (1-3).
Several aspects deserve special attention regarding
septic patients. In addition to hemodynamic, infectious and
immune response evaluations, metabolic parameters are
also relevant. Organic metabolism is a dynamic process,
especially in pathological situations, with protein synthesis
and degradation continuing to occur. Carbon dioxide (CO2)
is produced mostly due to the oxidation of substrates,
which can be quantified by using stable isotopes. The
endocrine-metabolic response triggered by sepsis cannot
be avoided but can be treated by preventing greater tissue
injury on the basis of a detailed knowledge of metabolism.
One of the most important metabolic changes occurring
during sepsis/septic shock is the predominance of the
catabolic response of skeletal muscle. This response is
multifactorial and reflects the inhibition of amino acid up-
take and the reduction of protein synthesis, with acceler-
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ated protein breakdown (4). Protein degradation exceeds
protein synthesis leading to increased O2 consumption
(VO2), which, if not corrected, can be associated with
multiple organ dysfunctions.
The measurement of nutrient oxidation rate in critically
ill patients receiving nutritional therapy is of great interest
(5-7). There are few reports using stable isotopes such as
labeled carbon (13C) in sepsis/septic shock. It is possible to
obtain the CO2 recovery fraction in expired air by adminis-
tering labeled bicarbonate intravenously (NaH13CO2) (8).
Since the CO2 produced from the labeled substrate inter-
acts with the bicarbonate pool before being expired, it is
necessary to determine this 13CO2 recovery fraction in
expired air in order to study the oxidation rate for a given
substrate (for example, protein). This recovery fraction can
be used as a correction factor in the calculation of protein
oxidation in subsequent studies.
The objective of the present study was to measure the
13CO2 recovery fraction in expired air of critically ill patients
with sepsis or septic shock on mechanical ventilation who
were receiving enteral or parenteral nutritional treatment,
by continuous intravenous infusion of NaH13CO2.
Subjects and Methods
Subjects
A prospective clinical study was conducted in the Inten-
sive Care Center (Campus) of the University Hospital, Fac-
ulty of Medicine of Ribeirão Preto. The study was approved
by the Research Ethics Committee of the University Hospi-
tal, Faculty of Medicine of Ribeirão Preto and written in-
formed consent was obtained from the patients or persons
responsible for them (Process #4989/99, HCRP). The inves-
tigation involved 10 patients (4 men and 6 women aged 15 to
85 years with sepsis of any origin or septic shock after blood
volume restoration and hemodynamic stabilization. We in-
cluded patients in the period between the 2nd and 5th day of
evolution of the clinical picture, with an indication for invasive
mechanical ventilation, with oxygen fraction in inspired air
(FiO2) <0.6, mean arterial pressure >50 mmHg, hourly diure-
sis >50 mL/h, and requiring the use of nutritional therapy.
Exclusion criteria were: oliguric renal insufficiency of any
etiology, spontaneous ventilation, brain death and refusal to
participate by the patient or person responsible. The criteria
used for the diagnosis of sepsis and septic shock were those
established by the consensus conference of the American
College of Chest Physicians/Society of Critical Care Medi-
cine (9). The patients were divided into two groups according
to severity as determined by the prognostic index APACHE
II (Acute Physiologic and Chronic Health Evaluation) (10)
and by sepsis score (11). All patients were submitted to
blood volume restoration, mechanical ventilatory support
with a microprocessor-controlled ventilator (Bird 8400 STi
Bird Prod Corp., USA; Servo 900C Siemens, Sweden; Savina
Draegger, Germany), appropriate antibiotic therapy, and the
use of vasoactive drugs and nutritional therapy according to
the real energy expenditure calculated by indirect calorim-
etry (70% carbohydrates, 30% lipids in relation to total
calorie value, and approximately 1 g·kg-1·day-1 protein) ac-
cording to the diet standardized by HCFMRP-USP. The
patients were sedated with benzodiazepines and/or opiates,
and a muscle blocker was used when necessary. Indirect
calorimetry was performed on all patients using a portable
Deltatrac II Metabolic Monitor (Datex-Ohmeda, Finland)
coupled to the mechanical ventilator. Barometric and gas
pressure were calibrated before each set of measurements.
Calorimetry was performed during the 6 h of the protocol,
and mean VCO2 was calculated for each hour together with
expired air collection. The patients were weighed using a
portable scale (Slingscale 2002, Instrucom/Hill-Rom series,
Hillenbrand Industries, USA).
Patient age ranged from 28-78 years (median 56 years;
mean 55.1 ± 19 years). The APACHE II prognostic index
ranged from 17-37 (median 24.5; mean 25.9 ± 7.4), with a
calculated death risk with a median of 45 (29-88) and a
mean value of 60 ± 20%. Sepsis score showed a median
value of 18 and ranged from 11-26 with a mean of 19.1 ±
4.2. The intravenous use of the stable isotope (NaH13CO2)
did not alter the acid-base status of the patients, as con-
firmed by arterial gas measurement before and after the
study. Of the 10 patients studied, 8 (80%) died within 5
days.
Experimental design
The protocol lasted 6 h. Basal expired CO2 was deter-
mined before starting the infusion of bicarbonate with
labeled carbon (3.8 µmol/kg NaH13CO2 diluted in 0.9%
NaCl in ddH2O) and indirect calorimetry was used through-
out the study. After basal gas collection, 5 mL NaH13CO2
was infused in bolus, followed by continuous infusion at 5
mL/h for 6 h (T1 to T6). The mean value obtained for each
hour (time) of study was used as the basis for the calcula-
tion of 13CO2 recovery fraction in expired air. For the
calculation of the recovery fraction, we used VCO2 (con-
verted from mL/min to mmol·kg-1·h-1) obtained by indirect
calorimetry and the 13CO2 value in expired air.
The dose of NaH13CO2 was calculated according to the
weight of the patient on the day when the protocol was
applied. The dose used for bolus infusion (prime) was 3.8
µmol/kg and the dose for continuous infusion was 3.8
µmol·kg-1·h-1, based on the study of Tissot et al. (12). The
stable isotope used was NaH13CO2 (99 atm%; Mass Trace
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Technologies, USA). The isotope was prepared in the
Pharmacy Division of the University Hospital of Ribeirão
Preto under a laminar flow hood and under aseptic and
antiseptic conditions.
Arterial gases were measured before and after the
study to determine possible interferences of the amount of
NaH13CO2 with the metabolic state of the patient.
Expired air was initially collected to establish a basal
reference value at times -40, -25, and -15 min before the
beginning of isotope infusion. Two samples per hour were
then collected throughout the procedure (6 h of isotope
infusion). Collection was performed with a 750-mL gas
collecting bag (Quintron, USA) connected to the expiratory
outlet of the mechanical ventilator. The samples were
analyzed by mass spectrometry using isotope ratio mass
spectrometry (Europa Scientific, England).
Equations used for the calculation of VCO2, the 13CO2
enrichment as well as 13CO2 recovery fraction in expired air
samples were previously described in the literature (13,14).
The value for Enr 13CO2 APE (enrichment of expired air in
percent of excess atoms) x 1000 refers to the arithmetic
difference between the 13CO2 values obtained for expired
air samples and the basal values before NaH13CO3 admin-
istration.
Statistical analysis
Data sets were first evaluated by Minitab 13.20 soft-
ware (USA) to test three hypotheses: independence, nor-
mality and variance in order to assess their parametric or
non-parametric nature. Considering the non-parametric
nature of all data sets, comparison between the two groups
studied according to severity was performed using the
non-parametric Wilcoxon sign post-test for two correlated
samples, with the level of significance set at P < 0.05. Data
are reported as median (min-max) as well as mean ± SD.
Additionally, non-parametric Spearman correlation coeffi-
cients were also determined between 13CO2 recovery frac-
tion and the minute volume and the VCO2.
Results
The median energy expenditure for the patients was
calculated to be 1493 ranging from 1131-2353 and mean
value of 1587 ± 430 kcal/min, with a value of 1440 ± 121
kcal/min when the Harris-Benedict equation (14) without
correction factors was used, avoiding the super-estimation
that the correction factor yields in the energy expenditure
values. Using this approach, the difference between the
two methods (146 kcal/min) was non-significant (P = 0.43).
The median value of minute volume was 7.6 (5.2-11.1)
with a mean of 7.7 ± 1.8 L/min, indicating that the alveolar
minute ventilation was within normal limits. This suggested
a low possibility of interference of CO2 elimination with the
recovery fraction since partial CO2 pressure (paCO2) re-
mained stable. Mean CO2 production was 182 ± 52 mL/
min, also corresponding to values within normal limits
(Table 1).
Median O2 consumption was 216 (140-343) with a
mean of 229 ± 67 mL/min, which remained stable through-
out the study. This was expected because the patients,
despite their septic shock condition, were stable due to the
hemodynamic support provided. The median respiratory
quotients of 0.8 ranging from 0.57-0.90 with a mean of 0.79
± 0.10 characterized an adequate metabolic state, with no
predominance of lipolysis, of gluconeogenesis or of lipo-
genesis (Table 1).
Mean 13CO2 enrichment in expired air was 4.01 ± 0.76
(APE x 1000) during the period from 120 to 360 min.
Table 1. Real energy expenditure, minute volume, CO2 production (VCO2), oxygen consumption (VO2), respiratory quotient, and
13CO2 recovery fraction in the patients studied.
Patient Energy expenditure Minute volume VCO2 VO2 Respiratory 13CO2 recovery
(kcal/min) (L/min) (mL/min) (mL/min) quotient fraction
1 1191 6.0 149 174 0.85 0.71
2 1155 7.9 145 140 0.9 0.68
3 2258 10.0 277 327 0.84 0.74
4 1455 8.5 168 215 0.78 0.70
5 1458 6.4 165 217 0.76 0.70
6 1565 6.9 165 211 0.78 0.60
7 1773 7.5 158 277 0.57 0.70
8 1131 5.2 146 163 0.89 0.55
9 2353 11.1 281 343 0.82 0.72
10 1528 7.6 162 225 0.72 0.72
Median (min-max) 1493 (1131-2353) 7.6 (5.2-11.1) 163.5 (145-281) 216 (140-343) 0.80 (0.57-0.90) 0.70 (0.55-0.74)
Mean ± SD 1587 ± 430 7.7 ± 1.8 182 ± 2 229 ± 67 0.79 ± 0.10 0.68 ± 0.06
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Dynamic evaluation throughout the study demonstrated
the presence of a steady state at about 2 h after the
beginning of isotope infusion, an expected result due to the
administration of the initial priming dose. A gradual in-
crease in enrichment occurred thereafter, reaching a steady
state in 120 min. No significant difference in enrichment
was observed between groups of different septic severity
(P = 0.99) (data not shown).
There was a positive, although weak, correlation be-
tween enrichment and minute volume and real energy
expenditure, suggesting that alveolar ventilation and the
diet offered somehow affected the percentage of 13CO2
enrichment in expired air.
The median 13CO2 recovery fraction in expired air was
0.70 (range 0.55-0.74) with a mean of 0.68 ± 0.06, differing
from those reported for non-septic critically ill patients,
which suggests that at some time during the course of
septic shock there may have been a shift of CO2 to other
metabolic pathways. Comparison of the 13CO2 recovery
fraction between different groups according to age (P =
0.81), sex (P = 0.25) and severity of disease (P = 0.62) did
Figure 2. Correlation of the 13CO2 recovery fraction in expired air and the minute volume, VCO2 and VO2 values for the 10 patients
studied. Spearman correlation test was used for statistical analysis as described in Methods (P < 0.05).
Figure 1. Correlation of the 13CO2 recovery fraction in expired air
and the real energy expenditure for the 10 patients studied.
Spearman correlation test was used for statistical analysis as
described in Methods (P < 0.05).
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not identify statistically significant differences (data not
shown). Again, comparison of patient groups selected
according to serum urea and bicarbonate levels did not
reveal statistically significant differences (P = 0.99 and P =
0.25, respectively) (data not shown).
When groups were compared according to VCO2 val-
ues, we observed that 2 patients had VCO2 above normal
(>200 mL/min) and 8 patients had VCO2 <200 mL/min.
When groups categorized according to VCO2 values and
APACHE II above and below the mean were compared, 7
patients were found to present APACHE II above the mean
and 3 were found to present APACHE II below the mean.
Among the 7 patients with APACHE II above the mean, 5
presented VCO2 above the mean, and all 3 patients with
APACHE II below the mean presented VCO2 below the
mean.
Regarding the route used for nutritional therapy, no
significant difference was observed between the 3 patients
receiving parenteral nutrition and the 7 patients receiving
enteral nutrition (P = 0.5) (data not shown).
There was a positive correlation between recovery
fraction and real energy expenditure (r = 0.62; Figure 1).
There was also a positive, although weak, correlation
between recovery fraction and minute volume (r = 0.58) as
well as VCO2 and VO2 (r = 0.75, r = 0.57; Figure 2).
Discussion
In the present study, we evaluated for the first time the
13CO2 recovery fraction in expired air from septic patients
divided into groups according to severity. One of the initial
objectives was also to correlate the 13CO2 recovery frac-
tion in expired air with the metabolic variable obtained by
indirect calorimetry, i.e., VO2, VCO2, minute volume, and
real energy expenditure.
The use of 13CO2 permits the study of CO2
metabolism and of its pathways of action. The
technique is based on the principle of injection of
a substance enriched with 13C into blood circula-
tion and evaluation of the recovery fraction of this
substance in collected expired air. Furthermore,
the 13CO2 estimation is required for whole-body
protein turnover, using the 13C-leucine technique
(13). Indeed, protein kinetics can be quantified
from the rate at which labeled leucine is released
from protein and the amount of leucine per gram
protein. The leucine oxidation is calculated from
the ratio of its first step metabolite α-ketoisocaproic
acid (13C-KIC measured in blood) and 13CO2 pro-
duction, corrected for the retention of 13CO2 in the
bicarbonate pool (fractional recovery). Moreover,
several studies have assessed the 13CO2 recovery fraction
in experimental animals and in humans by infusing
NaH13CO2, with results ranging from 0.51 to 0.95 (Table 2)
(8,12,15-22).
Several studies have reported variation in the 13CO2
recovery fraction in adults (17,20,22,23). In resting adults,
this rate may range from 0.52 to 0.94 during fasting and
from 0.72 to 0.90 during feeding. Several factors may
explain the discrepancies detected in these studies, such
as patient age, metabolic or nutritional status, the pres-
ence of underlying pathological conditions, and, espe-
cially, the conditions under which the experimental proto-
col was carried out.
The few studies available about critically ill patients
under mechanical ventilation did not distinguish between
specific diseases and this cannot be extrapolated to any
one specific disease. According to Tissot et al. (12), 13CO2
recovery fraction in expired air of stable critically ill patients
under mechanical ventilation was 0.89 ± 0.26, suggesting
that a percentage is retained in the organism, with possible
utilization in other metabolic pathways that have not been
fully clarified.
The principle behind the use of stable isotopes as-
sumes that the element (carbon 13) will be recognized by
the organism as the natural element which already exists,
since the two elements share the same chemical proper-
ties. The isotope will have to reach equilibrium within pre-
existing metabolic pathways. The quantity of the isotope
that enters the pool is equal to the amount that leaves the
pool. In this case, the entry is represented by the adminis-
tration of the substance and the exit by its oxidation. In
order to reach stability more rapidly, in the present study a
priming dose of the isotope that led to steady state within
approximately 120 min was administered. Without this
priming dose, this equilibrium would have been reached
Table 2. Measurement of 13CO2 recovery fraction in expired air during
NaH13CO2 infusion in different situations.
Patients Nutritional therapy Recovery fraction Reference
Adults Fasting 0.81 8
Adults Fasting 0.51 15
Adults Fasting 0.74 16
Adults Postprandial and physical 0.78 to 0.98 17
exercise
Child Postprandial 0.57 18
Adults Fasting 0.73 19
Adults Feeding 0.82 19
Healthy Fasting 0.52 to 0.95 20
Newborn Postprandial 0.96 21
Critically ill Postprandial 0.9 12
Trauma Fasting and postprandial 1.0 22
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within an interval as long as 24 h (8). The duration of the
present study was 360 min in order to provide a safe and
detailed evaluation of the kinetics of 13CO2. When NaH13CO2
was administered intravenously and its recovery fraction in
expired air was determined, we noted that the isotope was
not fully recovered. Clinical studies evaluating the 13CO2
recovery fraction in expired air have reported values rang-
ing from 0.52 to 0.95. Values below 1 indicate that the
injected isotope fraction is not fully eliminated as 13CO2 in
expired air. Three main destinations have been identified
thus far for the retention of this isotope in the organism.
First, 13CO2 may be incorporated into the synthesis of urea
(15). Second, 13CO2 may be incorporated into intermediate
metabolites such as oxaloacetate or malate (15,24). Fi-
nally, 13CO2 may participate in an exchange in the system
of bone bicarbonate, contributing to increase its concen-
tration in the osseous pool, with a consequent reduction in
plasma flow. An experimental study on rats (25) demon-
strated that, after 120 min of infusion, 7 to 10% of NaH14CO2
is recovered in the skeleton. Considering the 13C incorpo-
ration into urea, we evaluated seric urea levels and de-
tected no significant difference in 13CO2 recovery fraction
in expired air between groups with high and normal urea
levels.
Since 13CO2 is diluted in a pre-existing bicarbonate
pool, we can rule out the possible interference of the basal
serum bicarbonate level with the 13CO2 recovery fraction in
expired air. If the basal bicarbonate value is elevated, 13C
will be diluted in a larger pool and therefore the chance of
its elimination in expired air may be lower than in cases
with lower bicarbonate levels. No significant difference
was detected between patients with low and high bicarbo-
nate levels.
Other factors may interfere with 13CO2 retention in the
organism, such as moderate and prolonged physical exer-
cise, obesity (26), critical patient status (13), and fasting
(8,16,17,20,21) or postprandial (18,22,23) condition.
CO2 production should also be considered to be a
factor that may interfere with the 13CO2 recovery fraction in
expired air. Since this variable may be affected by several
factors, especially alveolar ventilation and oxidative stress,
we evaluated selected patients in terms of their VCO2
values. Assuming that 13CO2 is eliminated by the lungs, the
alveolar minute ventilation may interfere with its elimina-
tion and consequently affect the 13CO2 recovery fraction in
expired air. Alveolar minute ventilation probably did not
interfere with VCO2 values since the ventilatory pattern
remained stable and physiological throughout the study
protocol. On the other hand, the body weight factor, which
determines the amount of bicarbonate infused and the
individual metabolism, may alter the VCO2 value. On this
basis, a lower amount of 13CO2 elimination would be ex-
pected by patients with higher VCO2. However, 2 patients
presented VCO2 above normal values (>200 mL/min),
while 7 patients presented VCO2 below normal values and
the 13CO2 recovery fraction in expired air was similar for
both groups.
In the present study, the 13CO2 recovery fraction was
0.68 ± 0.06 in septic patients receiving nutritional therapy.
There was no statistically significant difference between
13CO2 recovery fraction in patients with sepsis of different
severity, according to the APACHE II index and sepsis
score. The same occurred when we evaluated different
groups selected according to age and gender. The varia-
tion (0.68 ± 0.06%) among the patients was 8.8%, demon-
strating that the result was homogeneous for the popula-
tion studied. This result is important because the popula-
tion of septic patients is intrinsically heterogeneous but, in
this context, the heterogeneity did not interfere with the
present measurements.
The factor that probably contributed most to the 13CO2
recovery fraction in expired air was the metabolic rate.
Wolfe (17) reported an increase in recovery fraction from
0.78 to 0.98 during intense and prolonged exercise. The
same increase was detected by Hoerr et al. (20) in re-
sponse to diet, with a positive correlation between VO2,
VCO2, real energy expenditure and 13CO2 recovery frac-
tion in expired air in adults. However, Tissot et al. (12)
detected a positive, although weak, correlation between
the recovery fraction and VO2 and real energy expenditure
(r = 0.55 for both, with P < 0.05) and found no correlation
between the recovery fraction and VCO2. On this basis,
care should be taken in interpreting these data because of
the risk of mathematical coupling between parameters that
share common variables (27,28). This risk is higher for the
correlation between the recovery fraction (RF) and CO2
production (VCO2): [RF = (VCO2 x 13CO2 Enr)/(F x 0.99)].
On the other hand, minute volume is a variable used to
calculate both recovery fraction and VO2. In the present
study, there was a positive, although weak, correlation
between minute volume and 13CO2 recovery fraction in
expired air (r = 0.58) and a better correlation between real
energy expenditure and 13CO2 recovery fraction in expired
air (r = 0.62) and between VO2 and 13CO2 recovery fraction
in expired air (r = 0.75). These findings suggest that the
correlation between these variables (VO2 and 13CO2 re-
covery fraction in expired air) was not the result of simple
mathematical coupling since the variable shared by the
two parameters (minute volume) did not correlate with
13CO2 recovery fraction in expired air. Since VO2 is a
variable related to survival (29), the 13CO2 recovery frac-
tion in expired air might play a similar role, a fact that was
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not demonstrated in the present study, perhaps owing to
the small number of patients evaluated. This line of rea-
soning is particularly relevant if we assume that a lower
13CO2 recovery fraction in expired air may be related to
greater severity, i.e., that a lower 13CO2 recovery may
mean that 13CO2 is being shifted to alternative metabolic
pathways that may be activated in order to resolve the
injury in question.
However, the occurrence of incomplete 13CO2 recov-
ery in expired air has not been fully explained because
there are no consistent data documenting in which organic
compartment the isotope is lost. It is possible that a signifi-
cant portion of the isotope is incorporated through alterna-
tive metabolic pathways that may function in different
manners according to the pathological condition involved.
Studies are needed to elucidate the values of the recovery
fraction in different groups according to age, nutritional
therapy and specific pathological conditions in order to
better interpret the oxidation of substrates. On this basis,
we can use an additional path, little explored until now, to
alter the prognosis, to validate new treatment modalities
and perhaps to improve the survival of patients with sepsis
and septic shock.
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